OmanDocSign in

Curriculum · Screening (National/International)

Colorectal cancer screening and surveillance

What it is

Screening for colorectal cancer is recommended for average-risk individuals beginning at age 50. National guidelines vary, and it is generally advised to start routine colon cancer screening between ages 45 and 50. Between ages 75 and 85 screening is more individualized. The factors to weigh are life expectancy, the patient's overall health, whether the patient has been screened previously, and patient preference. Most guidelines recommend stopping colon cancer screening in patients older than 85 years, or when life expectancy falls below 10 years.

Causes and risk

Higher risk means a personal history of adenomatous polyps, colorectal cancer, inflammatory bowel disease or a genetic cancer syndrome, or a family history of adenomatous polyps or colorectal cancer. The family history sets the age:

A second page names the risk factors at greater length: aging over 40; family history of colorectal cancer, familial adenomatous polyposis, Peutz-Jeghers syndrome, juvenile polyposis syndrome or hereditary nonpolyposis colorectal cancer; a past history of colorectal adenomas, serrated polyps or inflammatory bowel disease; and smoking, alcohol, obesity and radiation. On that page the ages are 45-75 years with no risk factors, and with high risk factors before 10 years or at the age of 40 yrs.

How it is diagnosed

Small distal hyperplastic polyps are considered a normal colonoscopy. After an adequate colonoscopy there is no need for referral to a gastroenterologist and no need for interval fecal immunochemical testing. The methods named are colonoscopy every 10 yrs, flexible sigmoidoscopy, flexible sigmoidoscopy plus FIT every 10 yrs, fecal occult blood testing (FOBT) every year, and fecal immunochemical testing (FIT) every year. Minimal BRBPR is worked up by age. Age 50 or older: most authors agree that colonoscopy is the test of first choice in patients over 50 to 55 years of age, and colon cancer screening is recommended regardless of the presence or absence of identified anorectal pathology on clinical examination. Ages 40 to 50: patients with minimal BRBPR who do not appear to be at increased risk for colorectal cancer based on their presentation and history should undergo at least a sigmoidoscopy, and colonoscopy should be considered if no source of bleeding is identified on sigmoidoscopy. Age less than 40: patients with minimal BRBPR are at low risk of colorectal cancer, so further evaluation is not necessary if the presentation and history do not suggest an increased risk of cancer and a potential source of bleeding, such as hemorrhoids or an anal fissure, is identified on physical examination or anoscopy or proctoscopy; if no potential source is identified, such patients should undergo sigmoidoscopy or perhaps colonoscopy.